[Dissecting the pathways of tumour escape: " question of life and death?"].

scientific article published in March 2010

[Dissecting the pathways of tumour escape: " question of life and death?"]. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1590/S0365-05962010000200022
P698PubMed publication ID20520947

P2093author name stringGeorgi Tchernev
Pietro Nenoff
P2860cites workProapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteinsQ24302494
Natural selection of tumor variants in the generation of "tumor escape" phenotypesQ24551158
The kiss of death: promises and failures of death receptors and ligands in cancer therapyQ28206616
The transcriptional targets of p53 in apoptosis controlQ28248026
Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donorsQ28259065
The mitochondrial serine protease HtrA2/Omi: an overviewQ28263602
Dissecting the pathways to deathQ33181665
Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosisQ33236007
HLA-G: a tolerance molecule from the major histocompatibility complexQ33546847
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?Q34064605
Caspases: more than just killers?Q34207528
Tumor counterattack: fact or fiction?Q34418305
Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death.Q35020684
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.Q35052176
A decade of caspasesQ35591686
Tumour escape: antitumour effectors too much of a good thing?Q35611475
Regulation of caspase-9 activity by differential binding to the apoptosome complexQ35792765
Caspases, IAPs and Smac/DIABLO: mechanisms from structural biologyQ35874476
Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications.Q35874924
Positive and negative consequences of Fas/Fas ligand interactions in the antitumor responseQ35966393
Transcription, apoptosis and p53: catch-22.Q36056198
Escape from immune- and nonimmune-mediated tumor surveillance.Q36248405
HLA-G in human reproduction: aspects of genetics, function and pregnancy complicationsQ36310336
Antigen mimicry, epitope spreading and the pathogenesis of pemphigusQ36616541
Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repelsQ36946423
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy.Q36960751
TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathwayQ37232979
HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometriumQ38440107
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.Q40150524
Expression of FasL in squamous cell carcinomas of the cervix and cervical intraepithelial neoplasia and its role in tumor escape mechanismQ40320998
Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytesQ40514646
Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.Q40736238
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escapeQ40736274
Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL.Q40980272
Inhibitory MHC class I receptors on NK cells and T cellsQ41113089
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.Q42064781
Arsenic trioxide (As(2)O(3)) induces apoptosis through activation of Bax in hematopoietic cellsQ45286126
Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.Q53271841
Frameshift Mutations in the Bax Gene Are Not Involved in Development of Ovarian Endometrioid CarcinomaQ53374898
[Cell cycle control, genetic instability and cancer]Q53445435
P433issue2
P304page(s)248-259
P577publication date2010-03-01
P1433published inAnais Brasileiros de DermatologiaQ15750855
P1476title[Dissecting the pathways of tumour escape: " question of life and death?"].
P478volume85

Reverse relations

Q47600992Pathways of tumor development and progression in drug-induced nonmelanoma skin cancer: a new hope or the next great confusion?cites workP2860